SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16342679
Source:
http://linkedlifedata.com/resource/pubmed/id/16342679
Search
Subject
(
64
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0002085
,
umls-concept:C0010762
,
umls-concept:C0017628
,
umls-concept:C0031327
,
umls-concept:C0055477
,
umls-concept:C0152035
,
umls-concept:C0205419
,
umls-concept:C0681850
,
umls-concept:C1332829
,
umls-concept:C1550501
,
umls-concept:C1706203
,
umls-concept:C1707203
,
umls-concept:C2349001
,
umls-concept:C2697811
pubmed:issue
9
pubmed:dateCreated
2005-12-13
pubmed:abstractText
To investigate the impact of CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam.
pubmed:language
chi
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/21710340R
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anti-Inflammatory Agents...
,
http://linkedlifedata.com/resource/pubmed/chemical/Aryl Hydrocarbon Hydroxylases
,
http://linkedlifedata.com/resource/pubmed/chemical/CYP2C9 protein, human
,
http://linkedlifedata.com/resource/pubmed/chemical/Glyburide
,
http://linkedlifedata.com/resource/pubmed/chemical/Hypoglycemic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Piroxicam
,
http://linkedlifedata.com/resource/pubmed/chemical/lornoxicam
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0513-4870
pubmed:author
pubmed-author:ChenXiao-YanXY
,
pubmed-author:GuoYing-JieYJ
,
pubmed-author:SiDa-YongDY
,
pubmed-author:ZhangYi-FanYF
,
pubmed-author:ZhongDa-FangDF
,
pubmed-author:ZhouHuiH
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
796-9
pubmed:meshHeading
pubmed-meshheading:16342679-Adult
,
pubmed-meshheading:16342679-Alleles
,
pubmed-meshheading:16342679-Anti-Inflammatory Agents, Non-Steroidal
,
pubmed-meshheading:16342679-Area Under Curve
,
pubmed-meshheading:16342679-Aryl Hydrocarbon Hydroxylases
,
pubmed-meshheading:16342679-Asian Continental Ancestry Group
,
pubmed-meshheading:16342679-China
,
pubmed-meshheading:16342679-Genotype
,
pubmed-meshheading:16342679-Glyburide
,
pubmed-meshheading:16342679-Humans
,
pubmed-meshheading:16342679-Hypoglycemic Agents
,
pubmed-meshheading:16342679-Male
,
pubmed-meshheading:16342679-Piroxicam
,
pubmed-meshheading:16342679-Polymerase Chain Reaction
,
pubmed-meshheading:16342679-Polymorphism, Genetic
,
pubmed-meshheading:16342679-Polymorphism, Restriction Fragment Length
pubmed:year
2005
pubmed:articleTitle
[Impact of cytochrome P450 CYP2C9 variant allele CYP2C9 * 3 on the pharmacokinetics of glibenclamide and lornoxicam in Chinese subjects].
pubmed:affiliation
Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, Shenyang 110016, China.
pubmed:publicationType
Journal Article
,
English Abstract
,
Research Support, Non-U.S. Gov't